LEXEO THERAPEUTICS INC (LXEO)

US52886X1072 - Common Stock

6.24  -0.04 (-0.64%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
520K1.66M
219.23%		650K
-60.84%
-100.00%		655.717K
-100.00%		29.07M163.71M
463.16%		394.02M
140.68%		705.46M
79.04%		1.883B
166.92%
EBITDA
YoY % growth
-4.59M-50.63M
-1,003.05%		-60.24M
-18.98%		-73.44M
-12.78%		-102M
-50.14%		-80.58M
21.00%		-81.6M
-1.27%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-4.59M-50.64M
-1,003.27%		-60.51M
-19.49%		-72.634M
-13.23%		-109.265M
-59.48%		-123.335M
-12.88%		-151.616M
-22.93%		-243.78M
-60.79%		-163.2M
33.05%		44.88M
127.50%		417.18M
829.55%		913.92M
119.07%
Operating Margin
-882.69%-3,050.60%-9,309.23%N/AN/A-18,809.20%N/A-838.60%-99.69%11.39%59.14%48.54%
EPS
YoY % growth
N/AN/AN/A-4.12-3.18
22.84%		-3.07
3.57%		-3.18
-3.79%		-3.63
-14.01%		-2.87
21.07%		1.00
134.88%		7.91
690.82%		17.13
116.65%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.82
3.14%		-0.81
-4.98%		-0.82
-28.70%		-0.82
8.03%		-0.84
-2.21%		-1.00
-23.66%		-1.04
-26.32%		-1.08
-32.09%		-1.04
-23.64%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-22.44M
-55.87%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-29.61M
-97.74%		-33.515M
-76.82%		-35.112M
-55.46%		-36.815M
-49.91%		-38.541M
-30.16%		-40.653M
-21.30%		-42.339M
-20.58%		-44.106M
-19.80%		-45.957M
-19.24%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.89
92.80%		-0.69-0.20-28.59%
Q2 2024
Q2Q % growth		 -0.64 -0.710.079.25%
Q1 2024
Q2Q % growth		 -0.77 -0.780.011.64%
Q4 2023
Q2Q % growth		 -0.85 -0.74-0.11-14.55%
Q3 2023
Q2Q % growth		 -12.36 -2.65-9.71-366.42%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth
-100.00%		%
Q1 2023
Q2Q % growth
-100.00%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% -12.81% -13.04%
RevenueN/A N/A N/A N/A